James G. Evans

Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: Can it be predicted using clinical parameters?

The presence of viable tumor in the surgical specimen after postchemotherapy retroperitoneal lymph node dissection (PC‐RPLND) is associated with an increased risk of disease progression. The objective of this study was to determine whether the presence of viable tumor in the surgical specimen could be predicted.

Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: Can we predict patients at risk of disease progression?

Patients with viable tumor at time of postchemotherapy retroperitoneal lymph node dissection (PC‐RPLND) are at an increased risk of disease progression. The objective of the current study was to determine the clinical variables that predict this adverse outcome.